Skip to main content

Table 1 The clinicopathological features of patients with PTC

From: Positive preoperative circulating tumor cells level associated with lymph node metastasis in papillary thyroid carcinoma patients with capsular invasion

Clinicopathological features

PTC patients (n = 746)

Age (Years)

 

 < 55, n (%)

612 (82.0%)

 ≥ 55, n (%)

134 (18.0%)

Gender

 

 Male, n (%)

140 (18.8%)

 Female, n (%)

606 (81.2%)

Thyroid function

 

 Normal, n (%)

661 (88.6%)

 Abnormal, n (%)

85 (11.4%)

Hashimoto’s thyroiditis

 

 No, n (%)

550 (73.7%)

 Yes, n (%)

196 (26.3%)

Multifocality

 

 No, n (%)

528 (70.8%)

 Yes, n (%)

218 (29.2%)

Maximum lesion diameter

 

 ≤ 1 cm, n (%)

515 (69.0%)

 > 1 cm, n (%)

231 (31.0%)

T stage

 

 T1-T2, n (%)

683 (91.6%)

 T3-T4, n (%)

63 (8.4%)

LNM

 

 No, n (%)

407 (54.6%)

 Yes, n (%)

339 (45.4%)

Preoperative CTCs (FU/3mL)

 

 Negative (< 8.7)

298 (39.9%)

 Positive (≥ 8.7)

448 (60.1%)

Capsular invasion

 

 No, n (%)

426 (57.1%)

 Yes, n (%)

320 (42.9%)

Surgical procedure

 

 Thyroid lobectomy, n (%)

466 (62.5%)

 Thyroidectomy, n (%)

179 (24.0%)

 Neck lymph node dissection, n (%)

101 (13.5%)

  1. PTC, papillary thyroid carcinoma; LNM, lymph node metastasis; CTC, circulating tumor cell; FU, folate receptor unit